Dr. Rhinehart is a Board-certified medical oncologist and hematologist serving patients in Fort Wayne, Indiana.
Dr. Rhinehart earned his medical degree from the Indiana University School of Medicine. He completed his residency in internal medicine at Blodgett Medical Center in Grand Rapids, Michigan, and his oncology and hematology fellowship at Methodist Hospital and the Indiana University School of Medicine.
Dr. Rhinehart is a member of the Allen County Medical Society, the American College of Physicians, the American Society of Clinical Oncology, and the Indiana Oncology Society, where he serves on the Board of Trustees. He is also a co-chair of the Lutheran Hospital Cancer Committee.
He has authored numerous studies, including:
- Safety and Effect on Platelet Count of Repeated Doses of Monoclonal Antibody to CD40 Ligand in Patients with Chronic ITP
- Collection of Peripheral Blood Progenitor Cells Following the Administration of Cyclophosphamide, Etoposide and Granulocyte-Colony Stimulating Factor: An Analysis of 497 Patients
- Phase II Multicenter Randomized Trial of Induction Weekly Paclitaxel Administered in Combination with Carboplatin Followed by Weekly Maintenance Verses Observation for Patients with Advanced and Metastatic Non-Small Cell Lung Cancer
Dr. Rhinehart enjoys working at Fort Wayne Medical Oncology and Hematology because of his colleagues’ unwavering dedication to putting patients first.
He is optimistic about the future of cancer care, encouraged by the ongoing advancements that continue to improve patients’ outcomes each year.